Alexza Pharmaceuticals Inc. Repurchase Agreements
3 Contracts & Agreements
- AZ-004 (Staccato loxapine). We are developing AZ-004 for the treatment of acute agitation in patients with schizophrenia or bi-polar disorder. In March 2007, we announced positive... (Filed With SEC on March 17, 2008)
- AZ-004 (Staccato loxapine). We are developing AZ-004 for the treatment of acute agitation in patients with schizophrenia or bi-polar disorder. In March 2007, we announced positive... (Filed With SEC on March 17, 2008)
- AZ-004 (Staccato loxapine). We are developing AZ-004 for the treatment of acute agitation in patients with schizophrenia or bi-polar disorder. In March 2007, we announced positive... (Filed With SEC on March 17, 2008)
